- Home
- SMTC vs BHVN Comparison
SMTC vs BHVN Comparison
Compare SMTC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- BHVN
- Stock Information
- Founded
- SMTC 1960
- BHVN 2013
- Country
- SMTC United States
- BHVN United States
- Employees
- SMTC 1917
- BHVN N/A
- Industry
- SMTC Semiconductors
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- BHVN Health Care
- Exchange
- SMTC Nasdaq
- BHVN Nasdaq
- Market Cap
- SMTC 3.2B
- BHVN 4.2B
- IPO Year
- SMTC N/A
- BHVN 2017
- Fundamental
- Price
- SMTC $37.10
- BHVN $36.85
- Analyst Decision
- SMTC Strong Buy
- BHVN Strong Buy
- Analyst Count
- SMTC 12
- BHVN 14
- Target Price
- SMTC $67.91
- BHVN $63.15
- AVG Volume (30 Days)
- SMTC 3.7M
- BHVN 752.7K
- Earning Date
- SMTC 03-27-2025
- BHVN 03-03-2025
- Dividend Yield
- SMTC N/A
- BHVN N/A
- EPS Growth
- SMTC N/A
- BHVN N/A
- EPS
- SMTC N/A
- BHVN N/A
- Revenue
- SMTC $851,233,000.00
- BHVN N/A
- Revenue This Year
- SMTC $6.70
- BHVN N/A
- Revenue Next Year
- SMTC $20.71
- BHVN $154.39
- P/E Ratio
- SMTC N/A
- BHVN N/A
- Revenue Growth
- SMTC 0.94
- BHVN N/A
- 52 Week Low
- SMTC $19.76
- BHVN $26.80
- 52 Week High
- SMTC $79.52
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- SMTC 29.94
- BHVN 40.96
- Support Level
- SMTC $36.11
- BHVN $38.40
- Resistance Level
- SMTC $39.86
- BHVN $42.82
- Average True Range (ATR)
- SMTC 2.99
- BHVN 2.14
- MACD
- SMTC -1.62
- BHVN -0.16
- Stochastic Oscillator
- SMTC 3.73
- BHVN 0.34
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments' 1) Signal Integrity, 2) Advanced Protection and Sensing, 3) IoT System and 4) IoT Connected Services. The majority of the company's revenue is earned through Advanced Protection and Sensing Products segment. Geographically majority of the company's revenue is earned from Asia Pacific region.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.